JAMA Network Home
Sign In
Editor's Pick Original Investigation

A Telemedicine-Supported Home-Injection Model for Patients With Breast Cancer

JAMA Network Open 10.1001/jamanetworkopen.2026.29406

August 21, 2026 at 11:00 AM EDT

Read the full article

In this quality improvement study of a telemedicine-supported home injection model for women with breast cancer, strong feasibility was demonstrated by high injection completion rates and acceptability by participants. The findings suggest that insurance approval and the copayments associated with at-home, but not in-clinic, administration were an impediment to participation and need to be addressed before scaling.

JAMA+ Women's Health

Explore JAMA+ Women's Health for more Women's Health research, commentary, multimedia, and resources from across JAMA Network.

Led by Editor in Chief Linda Brubaker, MD, JAMA+ Women's Health is a curated source of trusted clinical information that advances health care for women worldwide. Dr Brubaker is also a JAMA Deputy Editor.

Corresponding Author: Erin M. Bange, MD, MSCE, Department of Medicine, Memorial Sloan Kettering Cancer Center Sidney Kimmel Center for Prostate and Urologic Cancers, 353 E 68th St, New York, NY 10065 (bangee@mskcc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.29406?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082126

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks